ToxTracker included in webinar by Charles River: Avoid Program Set-Backs: Deciphering Positive Reponses
In a webinar on genetic toxicology by Charles River the ToxTracker assay was included. Via this link you can view the webinar, the information on ToxTracker starts at 38 minutes. ...
Toxys is part of organising committee for workshop: Mode of Action Approaches That Identify Genotoxic Mechanisms in Mammalian Cell Systems (May 10th 2017)
The HESI Genetic Toxicology Technical Committee (GTTC) will hold the workshop in conjunction with the Genetic Toxicology Association (GTA) annual meeting on 10 May 2017 in Newark, Delaware. The first part of the workshop is intended to establish key cellular and genetic events for defined...
Interview with Toxys CEO Giel Hendriks and cover spread in TerugbliQ – the year report from Innovation Quarter
In TerugbliQ, the year report from Innovation Quarter you can read an interview with our CEO Giel Hendriks (in Dutch), please click here for the year report and the interview...
Toxys mentioned as top-10 biotech in Leiden
In this article by Labiotech.eu Toxys is mentioned as one of the top-10 biotech companies in Leiden. Stroopwaffels, Krokets and Biotechs – Meet the Top 10 in Leiden! ...
Toxys awarded € 50.000 by EIT Health to develop ReproTracker – an in vitro assay for reproductive toxicity
21 September 2016 - Today Toxys was awarded a €50.000 grant for a head-start project to further develop the ReproTracker. Toxys is dedicated to develop innovative in vitro toxicity assays that provide insight into the mechanisms of toxicity. Toxys' lead product ToxTracker is a genotoxicity...
Grand Opening new facilities Toxys
On the 26th of May Toxys organised a grand opening party. Over 50 people joined, among which were Innovation Quarter, the Leiden Bioscience Park, Biopartner and various entrepreneurs and collaborators. We are very happy with our new location and state-of-the-art equipment and look forwards to expanding...
A Milestone for Toxys: Growth capital for biotech company Toxys to develop Toxicological tests
The Zeeuws Investment Fund and InnovationQuarter have invested in the biotech company Toxys, located in Leiden, The Netherlands. Toxys is a spin-off from the Leiden University Medical Centre (LUMC) and specialized in a new generation of innovative testing which quickly and reliably can identify the...
Toxys joins IVTIP
Toxys recently joined the In Vitro Testing Industrial Platform (IVTIP). IVTIP is an informal platform that was founded in 1993 and currently comprises 42 companies from different sectors (assay developers, technology providers, chemical, pharmaceutical and cosmetics companies), with significant in vitro testing activities. Most of the...
Toxys at Eurotox 2015
Our Poster Presentations The ToxTracker reporter system is a mechanistic genotoxicity platform that discriminates clastogenic from aneugenic compounds.Giel Hendriks1, Remco Derr1, Branislav Misovic2, Bruno Morolli2, Fabienne Calléja2 and Harry Vrieling2. 1 Toxys B.V., Albinusdreef 2, 2333 ZA, Leiden, the Netherlands. g.hendriks@toxys.com 2 Department of Human Genetics, Leiden University...
Toxys receives award for best business plan
Today at the SME event from HollandBio, Toxys received the award for best business plan as part of the BioBusiness Masterclass. A jury of experts in Life Sciences acknowledged the strong technology and business opportunities at Toxys. The award is a great support for Toxys...
